Indivior puts biggest investor on board in overhaul
24th Mar 2021 07:56
(Sharecast News) - Indivior has given Scopia Capital, its biggest investor, a place on its board as part of a governance overhaul by the prescription drugs group.
Read moreIndivior seeks growth after annual loss
18th Feb 2021 07:50
(Sharecast News) - Indivior plunged to an annual loss as the opioid addiction treatment maker's Suboxone drug lost market share and the company settled litigation related to the US opioid crisis.
Read moreIndivior says £1.1bn Reckitt claim 'without merit'
30th Nov 2020 07:49
(Sharecast News) - Indivior said on Monday that a £1.1bn claim against it by consumer goods group Reckitt Benckiser, which has yet to be served on the opioid addiction treatment maker, is "without merit" and that it has "strong grounds" for defending itself should the claim be served.
Read moreIndivior tumbles as Reckitt Benckiser makes £1bn claim
27th Nov 2020 11:44
(Sharecast News) - Indivior shares tumbled on Friday after the opioid addiction treatment maker said it had been made aware of a £1.07bn claim against it by consumer goods company Reckitt Benckiser.
Read moreIndivior appoints Ryan Preblick as CFO
20th Nov 2020 11:34
(Sharecast News) - Indivior has appointed Ryan Preblick as chief financial officer after he spent five months in the job on an interim basis.
Read moreIndivior's settlement with DoJ approved by US court
13th Nov 2020 07:03
(Sharecast News) - Indivior said a US court approved its agreement with the Department of Justice and other agencies and dismissed charges related to sales of its Suboxone opioid addiction treatment.
Read moreIndivior Q3 profit, revenue decline; new FY guidance outlined
29th Oct 2020 12:50
(Sharecast News) - Indivior reported a decline in third-quarter revenue and operating profit on Thursday but reinstated financial guidance as it said it expects to be profitable on an adjusted pre-tax basis for FY 2020.
Read moreFormer Indivior CEO sentenced in US Federal Court
23rd Oct 2020 08:19
(Sharecast News) - Pharmaceutical firm Indivior revealed on Friday that former chief executive Shaun Thaxter had been sentenced in United States Federal Court.
Read moreIndivior to axe jobs, restructure as it looks to cut costs
24th Sep 2020 08:35
(Sharecast News) - Opioid addiction treatment maker Indivior outlined plans on Thursday to reduce costs through job cuts and restructuring, as it looks to support long-term growth ambitions and protect its financial and operational flexibility in response to the pandemic.
Read moreIndivior 1H profits reduced by nearly three quarters amid pandemic
30th Jul 2020 07:48
(Sharecast News) - Indivior suffered a precipitous drop in sales and profits over the first half as the Covid-19 pandemic saw the number of new patients in the US for its anti-opioid addiction drug dry up.
Read moreMonday broker round-up
27th Jul 2020 13:24
(Sharecast News) - Indivior: Jefferies upgrades to buy with a target price of 200.0p.
Read moreIndivior surges again as Jefferies, Citi upgrade after $600m settlement
27th Jul 2020 11:16
(Sharecast News) - Indivior surged on Monday as Jefferies and Citi upgraded their ratings on the stock after the company reached a settlement with US authorities related to its opioid addiction treatment Suboxone.
Read moreWednesday broker round-up
22nd Jul 2020 13:45
(Sharecast News) - Resolute Mining: Berenberg reiterates buy with a target price of 90.0p.
Read moreIndivior appoints Mark Crossley as CEO
29th Jun 2020 07:44
(Sharecast News) - Indivior has promoted Mark Crossley to the role of chief executive officer, succeeding Shaun Thaxter.
Read moreWednesday broker round-up
17th Jun 2020 13:18
(Sharecast News) - Indivior: Jefferies reiterates hold with a target price of 70p.
Read more